Latest / Medical Device Global Market Access
Unlocking U.S. Clinical Studies: A Deep Dive into 21 CFR Part 812
This episode demystifies the U.S. FDA's 21 CFR Part 812 regulation for Investigational Device Exemptions (IDEs). We explore the purpose of an IDE, the critical differences between significant and non-significant risk device studies, and the corresponding regulatory requirements for sponsors, investigators, and IRBs to ensure compliance during clinical trials. Key Questions: • What is an Investigational Device Exemption (IDE) and when is it required? • How does the FDA classify devices as Significant Risk (SR) versus Non-Significant Risk (NSR)? • What are the different approval pathways for SR…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.